Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	49.58	-11.71	-23.22
Graham Fair Price	41.43	0.09	0.06
PEG	-65.50	-0.01	0.04
Price/Book	-18.76	1.45	1.78
Price/Cash Flow	-48.78	16.52	32.26
Prices/Earnings	59.38	-1.38	-3.40
Price/Sales	-59.38	1.71	4.20
Price/FCF	-48.78	16.52	32.26
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	273.71	0.16	-0.04
Operating Margin	12.15	-0.22	-0.25
ROA	-100.00	-0.06	-0.03
ROE	-0.13	-0.26	-100.00
ROIC	-0.06	-0.10	-63.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.09	-96.94
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.87	-0.76	-12.99
EPS QOQ	0.85	-1.00	17.74
FCF QOQ	1.61	0.59	-63.49
Revenue QOQ	-0.68	1.00	47.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	293.62	183.54	-37.49
Days Sales Outstanding (DSO)	61.00	30.50	-50.00
Inventory Turnover	0.31	0.49	59.98
Debt/Capitalization	0.45	0.45	0.15
Quick Ratio	0.17	0.17	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.04	0.04	< 0.005
Cash	< 0.005	< 0.005	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	< 0.005	< 0.005	58.64
Revenue	0.02	0.03	100.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.74	0.74	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.05	-3.55	41.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating